5641004: Valproate semisodium (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\...

\Psychoactive substance (substance)\Psychotropic agent (substance)\Valproate\Valproate semisodium

\Anticonvulsant\Valproate\Valproate semisodium

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Fatty acid\Unesterified fatty acid\Saturated fatty acid\Valproate\Valproate semisodium

\Lipid\Fatty acid\Unesterified fatty acid\Saturated fatty acid\Valproate\Valproate semisodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2154262012 Valproate semisodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2155284018 Divalproex sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3484640014 Valproate semisodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Valproate semisodium	Is a	Product containing valproic acid (medicinal product)	false	Inferred relationship	Some
Valproate semisodium	Is a	Valproate	false	Inferred relationship	Some
Valproate semisodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Valproic acid (substance)	true	Inferred relationship	Some
Valproate semisodium	Is a	Valproate	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sodium valproate 500mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Divalproex sodium 125mg capsule sprinkle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Divalproex sodium 125mg tablet delayed release	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Divalproex sodium 250mg tablet delayed release	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Divalproex sodium 500mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Divalproex sodium 500mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Valproate semisodium	Inferred relationship	Some
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Valproate semisodium	Inferred relationship	Some	1
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Valproate semisodium	Inferred relationship	Some	1
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Valproate semisodium	Inferred relationship	Some	1

This concept is not in any reference sets